Aug 29, 2024
Female sexual dysfunction is a well-studied adverse effect of cancer treatment. Despite its prevalence, however, it remains vastly underdiagnosed and undertreated in oncology patients, with providers inadequately addressing sexual function before, during, and after treatment. Although most patients prefer that their...
Aug 22, 2024
Effective partnerships between dermatologists and oncologists are an essential component of care coordination for patients with advanced non-melanoma skin cancers. This interprofessional collaboration can be more challenging in the community setting, where fewer resources are available in comparison to large academic...
Aug 15, 2024
Novel cancer therapies have emerged over the past 10-15 years with high rates of cutaneous side effects, leading to increased demand for specialists in oncodermatology. These subspecialists have expertise in managing therapeutic complications, cutaneous metastases, and proactive management of potential adverse events....
Aug 8, 2024
Common adverse events associated with treatment of mantle cell lymphoma include gastrointestinal, hematologic, and cardiac toxicities. Proactive management of these toxicities and collaboration between members of the cancer care team, including pharmacists, are key to optimizing patient outcomes. In this episode, CANCER...